16282S2308-NCT06337318OpenRandomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular LymphomaS2308NCT06337318NationalAdultTreatmentIIINon-Hodgkin LymphomaRoswarski, JosephGeorgetown University Medical Center : Ayodeji Olukoya; Lombardi Comprehensive Cancer Center : Ayodeji OlukoyaLymphomaOncology GroupLombardi Comprehensive Cancer Center (LCCC)16185Ayodeji OlukoyaAyodeji Olukoyaaoo42@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">&copy; 2026 Advarra, Inc.</a>